Phase 1 safety trial of Filgrastim (r-metHuG-CSF) in non-neutropenic patients with severe community-acquired pneumonia

Respiratory Medicine

Volumn 91, Issue 7, 1997, Pages 387-394

  Deboisblanc, B P ^a   Mason, C M ^b   Andresen, J ^a   Logan, E ^b   Bear, M B ^c   Johnson, S ^a,b   Shellito, J ^a   Summer, W R ^c   Nelson, S ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMGEN INC   (United States)

^c Pulmonary/Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTERIAL GAS; ARTICLE; BLOOD CELL COUNT; BLOOD CHEMISTRY; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; COMMUNITY HOSPITAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; MALE; MORBIDITY; MORTALITY; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; PULSE OXIMETRY; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPTOM; THORAX RADIOGRAPHY;

EID: 0030739651     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90250-X     Document Type: Article

References (37)

1. Centers for Disease Control. Final results: Medicare influenza vaccine demonstration - selected states. MMWR 1993; 42: 601-604.
2. Fine MJ, Orloff JJ, Arisumi D et al. Prognosis of patients hospitalized with community-acquired pneumonia. Am J Med 1990; 88: 1N-8N.
3. MacFarlane JT, Finch RG, Ward MJ, Macrae AD. Hospital study of adult community-acquired pneumonia. Lancet 1989; 2: 255-258.
4. Hook EW 3rd, Horton CA, Schaberg DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 1983; 249: 1055-1057.
5. Morstyn G, Nicola NA, Metcalf D. Separate actions of different colony stimulating factors from human placental conditioned medium on human progenitor cell survival and proliferation. J Cell Physiol 1981; 109: 133-142.
6. Begley CG, Metcalf D, Lopez AF, Nicola NA. Fractionated populations of normal human marrow cells respond to both human colony stimulating factors with granulocyte-macrophage activity. Exp Hematol 1985; 13: 956-962.
7. Metcalf D, Begley CG, Nicola NA. The proliferative effects of human GM-CSF alpha and beta murine G-CSF in microwell cultures of fractioned human marrow cells. Leuk Res 1985; 9: 521-527.
8. Begley CG, Niola N A, Metcalf D. Proliferation of normal human promyelocytes and myelocytes after a single pulse stimulation by purified GM-CSF or G-CSF. Blood 1988; 71: 640-645.
9. Lopez AF, Nicola NA, Burgess AW et al. Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors. J Immunol 1983; 131: 2983-2988.
10. Vadas MA, Lopez AF. Regulation of granulocyte function by colony-stimulating factors and monoclonal antibodies. Lymphokines 1985; 12: 179-200.
11. Heyworth CM, Ponting ILO, Dexter TM. The response of haemopoietic cells to growth factors: developmental implications of synergistic interactions. J Cell Sci 1988; 91: 239-247.
12. Glaspy J, LeMaistre CF, Lill M et al. Dose-response of 7 day administration of recombinant stem cell factor (SCF) in combination with Filgrastim (G-CSF) for progenitor cell mobilization in patients with stage II-IV breast cancer. Blood 1995 (submitted).
13. Gabrilove JL, Wakubowski A, Fain K et al. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 1988a; 82: 1454-1461.
14. Gabrilove JL, Jakubowski A, Scher H et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated mortality due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988b; 318: 1414-1422.
15. Morstyn G, Campbell L, Souza LM et al. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 1: 667-672.
16. Bronchud MH, Scarffe JH, Thatcher N et al. Phase 1/11 study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 1987; 56: 809-813.
17. Sheridan WP, Morstyn G, Wolf M et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; 2: 891-895.
18. Dale DC, Bonilla MA, Davis MW et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (Filgrastim) for treatment of severe chronic neutropenia. Blood 1993; 81: 2496-2502.
19. Stahel RA, Jost LM, Cermy T et al. Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies. J Clin Oncol 1994; 12: 1931-1938.
20. Crawford J, Ozer H, Stoller R et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer. N Engl J Mcd 1991; 315: 164-170.
21. Trillet-Lenoir V, Green J, Manegold C et al. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer 1993; 29A: 319-324.
22. Maher DW, Lieschke GJ, Green M et al. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann Intern Med 1994; 121: 492-501.
23. Nelson S. Granulocyte colony stimulating factor enhances pulmonary host defenses suppressed by alcohol. Am Rev Respir Dis 1990; 141: A530.
24. Hebert JC, O'Reilly M, Gamelli RL. Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch Surg 1990; 125: 1075-1078.
25. Smith WS, Sumnicht GE, Sharpe RW, Samuelson D, Millard FE. Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of Gram-negative pneumonia sepsis: analysis of survival and multisystem organ failure. Blood 1995; 86: 1301-1308.
26. Hogg JC. Felix Fleischner Lecture: the traffic of polymorphonuclear leukocytes through pulmonary microvessels in health and disease. Am J Roentgenol 1994; 163: 769-775.
27. Miller AB; Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
28. Nelson S, Daifuku R, Andresen J. Use of Filgrastim (r-metHuG-CSF) in infectious diseases. In: Morstyn G, Dexter MT, eds. Filgrastim (r-metHuG-CSF) in Clinical Practice. New York: Marcel Dekker, Inc., 1993, pp. 253-266.
29. King J, deBoisblanc BP, Mason CM et al. Effect of granulocyte colony-stimulating factor on acute lung injury in the rat. Am J Respir Crit Care Med 1995; 151: 302-309.
30. White-Owen C, Hartmann S, Alexander JW, Babcock GF. Reduced PMN beta 2 integrins after trauma: a possible role for colony-stimulating factors. Clin Exp Immunol 1993; 92: 477-481.
31. Ohsaka A, Saionji K, Sato N, Mori T, Ishimoto K, Inamatsu T. Granulocyte colony-stimulating factor down-regulates the surface expression of the human leucocyte adhesion molecule-1 on human neutrophils in vitro and in vivo. Br J Hematol 1993; 84: 574-580.
32. Kanazawa M, Ishizakz A, Hasegawa N, Suzuki Y, Yokoyama T. Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am Rev Respir Dis 1992; 145: 1030-1035.
33. Koizumi T, Kubo K, Shinozaki S, Koyama S, Kobayashi T, Sekiguchi M. Granulocyte colony-stimulating factor does not exacerbate endotoxin-induced lung injury in sheep. Am Rev Respir Dis 1993; 148: 132-137.
34. Fink MP, O'Sullivan BP, Menconi MJ, et al. Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs. J Trauma 1993; 34: 571-578.
35. Terashima T, Kanazawa M, Sayama K et al. Granulocyte colony-stimulating factor exacerbates acute lung injury induced by intratracheal endotoxin in guinea pigs. AmJRespir Crit Care Med 1994; 149:1295-1303.
36. Fruchtman SM, Gombert ME, Lyons HA. Adult respiratory distress syndrome as a cause of death in pneumococcal pneumonia. Report of ten cases. Chest 1983; 83: 589-601.
37. Stricter RM, Lynch JP, Basha MA, Standiford TJ, Kasahara K, Kunkel SL. Host responses in mediating sepsis and adult respiratory distress syndrome. Semin Respir Infect 1990; 5: 233-247.